CN1194730C - Cardiac and cerebral blood vessel nourishing tea - Google Patents
Cardiac and cerebral blood vessel nourishing tea Download PDFInfo
- Publication number
- CN1194730C CN1194730C CNB021325480A CN02132548A CN1194730C CN 1194730 C CN1194730 C CN 1194730C CN B021325480 A CNB021325480 A CN B021325480A CN 02132548 A CN02132548 A CN 02132548A CN 1194730 C CN1194730 C CN 1194730C
- Authority
- CN
- China
- Prior art keywords
- blood
- tea
- radix
- cerebral
- cardiac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention discloses a tea for nursing cardiac and cerebral blood vessels, which is prepared from milkvetch root, angelica, folium mori, folium ginkgo, uncaria, tuckahoe, notoginseng, radix rehmanniae, radix glycyrrhiza, chuanxiong rhizome and vegetable caterpillar by a traditional process for preparing Chinese patent medicines. The tea for nursing cardiac and cerebral blood vessels is mainly used for accessorily treating diseases such as coronary disease, cerebral embolism, cerebral infarction, cerebrovascular spasm, hyperlipoidemia and high blood viscosity, and the tea has the functions for promoting blood circulation to remove blood stasis, benefiting the heart to astringe the lung, eliminating dampness to stop diarrhea, strengthening the spleen to benefit qi, regulating yin and yang, reducing whole blood viscosity, improving blood flow change, reducing blood fat, regulating blood pressure in two directions and preventing caducity. The tea is prepared from the green plants of the pure Chinese herbal medicines, and has small toxic and side effects. Particularly, the tea has the advantages of no toxin and no harm to viscera such as livers, kidneys, etc., obvious curative effect and obvious disappearance of clinical symptoms.
Description
Technical field:
The present invention relates to the medicine of cardio-cerebralvascular diseases, say it is to disclose a kind of cardiac and cerebral blood vessel nourishing tea clearly, belong to Chinese medicine treatment cardiovascular medicament.
Background technology:
Cardiovascular and cerebrovascular disease is a kind of frequently-occurring disease and commonly encountered diseases, has the sickness rate height, and the characteristics that cure rate is low at present, have much for this sick medicine, but have obvious curative effects seldom, have influenced cardiovascular and cerebrovascular disease patient's treatment.
Summary of the invention:
Characteristics such as the present invention discloses a kind of cardiac and cerebral blood vessel nourishing tea, and it is obvious to have curative effect, and clinical symptom disappearance is rapid.
The present invention is the basis according to China's Chinese medicine to the pathogeny of cardio-cerebralvascular diseases and Therapeutic Principle, with reference to modern medical theory, with strengthening vital QI to eliminate pathogenic factors, QI invigorating is enriched blood, blood circulation promoting and blood stasis dispelling and making laws, select for use and have invigorating the spleen and benefiting QI, regulate negative and positive, improve the pure natural Chinese herbal medicine of effect such as blood flow viscosity, by the theory of Chinese medical science prescription,, make cardiac and cerebral blood vessel nourishing tea in conjunction with modern advanced technologies method for making through the strictness screening.
Medicine of the present invention is made by ratio of weight and the number of copies by following drug component:
The Radix Astragali 35～45, Radix Angelicae Sinensis 5～15, Folium Mori 40～60, Folium Ginkgo 25～40,
Ramulus Uncariae Cum Uncis 15～25, Poria 30～40, Radix Notoginseng 5～15, Radix Rehmanniae 25～38,
Radix Glycyrrhizae 8～15, Rhizoma Chuanxiong 5～15, Cordyceps 8～15.
Preferred prescription of the present invention is:
The Radix Astragali 40, Radix Angelicae Sinensis 10, Folium Mori 50, Folium Ginkgo 30, Ramulus Uncariae Cum Uncis 25,
Poria 30, Radix Notoginseng 10, Radix Rehmanniae 30, Radix Glycyrrhizae 15, Rhizoma Chuanxiong 10,
Cordyceps 12.
Concrete processing procedure is as follows:
Take by weighing said medicine respectively, the inspection removal of impurity, sieve dust removal soil is cleaned oven dry, and pulverize separately becomes 20～80 order fine powders, mix homogeneously, sterilization back packing is made medicine of the present invention.
Instructions of taking: soak more than 12 hours with 10～20 times of boiled water in cool-bag for 30 gram/every days, the daily water yield is drunk; Also can be directly oral at twice.
Function cures mainly: the auxiliary treatment that is used for coronary heart disease, cerebral thrombosis, cerebral infarction, cerebral vasospasm, hyperlipidemia, high blood dense disease.
The present invention can be made into other dosage forms such as said powder, watered pill, water decoction, capsule on the pharmaceutics.
In the present invention with the Radix Astragali, when being classified as monarch, strongly invigorating QI and blood; With Folium Ginkgo, Rhizoma Chuanxiong is minister, can activating blood circulation to dissipate blood stasis, and can help monarch's QI invigorating to enrich blood again; Ramulus Uncariae Cum Uncis, Radix Rehmanniae, Folium Mori are assistant, and the neck monarch drug is mended and not dry, form the method for the treatment of YANG within YIN, and tonifying kidney-yin, suppressing liver-wind are again arranged, and be coordinating water and fire, the merit of the capable reinforcing the heart lung of assistant monarch drug; Assistant is with Poria, Cordyceps tonifying the lung kidney, the saliva that eliminates the phlegm, and strengthens astringent or styptic treatment for spontaneous sweating clear respectful power, the capable QI invigorating of the monarch drug of rendering meritorious service it; Radix Glycyrrhizae, Radix Notoginseng are for making, and promptly principal drug assistance pulls together to go forward side by side, and draw monarch drug again and directly go into heart palace, the power of row inrigorating qi and promoting blood circulation, the blood stasis dispelling row heart.
Further specify the curative effect of medicine of the present invention below with regard to clinical effectiveness of the present invention:
One, curative effect determinate standard
Produce effects: treatment back symptom disappears substantially, and blood pressure, electrocardiogram, blood fat, blood viscosity are recovered normal value fully.
Effectively: treatment back symptom is obviously improved, and blood pressure, electrocardiogram, blood fat, blood viscosity make moderate progress.
Invalid: treatment back symptom does not have obvious improvement, and blood pressure, electrocardiogram, blood fat, blood viscosity are for reaching above-mentioned standard, and complication is not controlled.
Two, the therapeutic effect of medicine of the present invention
Selected 374 routine out-patients, male's 168 examples, women's 179 examples, 29～94 years old age, the course of disease 1 month～40 years is taken medicine of the present invention and is treated; Matched group 67 examples, male's 29 examples, women's 38 examples, at 40～70 years old age, the course of disease 2 months～40 years is taken brain heart health medicine and is treated.Carrying out statistical analysis through system's clinical observation is summarized as follows:
| Group | Case load | Produce effects | Effectively | Invalid | Obvious effective rate % | Total effective rate % |
| Take medicine of the present invention | 152 | 129 | 21 | 2 | 85 | 98.60 |
| Self-controlled group | 148 | 118 | 23 | 7 | 79 | 95.8 |
| Brain heart health treatment group | 47 | 43 | 3 | 1 | 97.80 | |
| Matched group | 67 | 46 | 15 | 6 | 68 | 76.00 |
Three, clinical observation is summed up
Pharmic function of the present invention: activating blood circulation to dissipate blood stasis, the beneficial heart are astringed the lung, removing dampness antidiarrheal, spleen invigorating QI invigorating, regulate negative and positive, improve the whole blood viscosity, improve hemorheology, blood fat reducing, two-ways regulation blood pressure, defying age.
Good effect of the present invention is: preparation is that pure Chinese herbal medicine green plants is made, and toxic and side effects is little, and particularly nontoxic to internal organs such as Liver and kidney, evident in efficacy, clinical symptom disappearance is obvious.
The specific embodiment:
Embodiment 1
Take by weighing Radix Astragali 40kg, Radix Angelicae Sinensis 10kg, Folium Mori 50kg, Folium Ginkgo 30kg, Ramulus Uncariae Cum Uncis 25kg, Poria 30kg, Radix Notoginseng 10kg, Radix Rehmanniae 30kg, Radix Glycyrrhizae 15kg, Rhizoma Chuanxiong 10kg, Cordyceps 12kg, the inspection removal of impurity, sieve dust removal soil, clean oven dry, pulverize separately becomes 20 order fine powders, behind the high temperature sterilize, and mix homogeneously, make 30g/ bag shape packing, make medicine of the present invention.
Embodiment 2
With Radix Astragali 45kg, Radix Angelicae Sinensis 10kg, Folium Mori 55kg, Folium Ginkgo 36kg, Ramulus Uncariae Cum Uncis 20kg, Poria 35kg, Radix Notoginseng 15kg, Radix Rehmanniae 30kg, Radix Glycyrrhizae 20kg, Rhizoma Chuanxiong 10kg, Cordyceps 10kg, the inspection removal of impurity, sieve dust removal soil, it is stand-by that wherein half medicine is ground into 80 purpose fine powders; Remaining part adds four times of water gagings and decocts twice, and each 2 hours, collecting decoction, filter, filtrate is concentrated into relative density 1.20～1.25 (80～85 ℃), with above-mentioned fine powder mix homogeneously, xeraphium becomes fine powder, is that wetting agent is made granule with 60% ethanol, drying, granulate, sterilization packaging.
Claims (2)
1, a kind of cardiac and cerebral blood vessel nourishing tea is characterized in that being made by following materials of weight proportions:
The Radix Astragali 35～45, Radix Angelicae Sinensis 5～15, Folium Mori 40～60, Folium Ginkgo 25～40,
Ramulus Uncariae Cum Uncis 15～25, Poria 30～40, Radix Notoginseng 5～15, Radix Rehmanniae 25～38,
Radix Glycyrrhizae 8～15, Rhizoma Chuanxiong 5～15, Cordyceps 8～15.
2, cardiac and cerebral blood vessel nourishing tea according to claim 1 is characterized in that being made by following materials of weight proportions:
The Radix Astragali 40, Radix Angelicae Sinensis 10, Folium Mori 50, Folium Ginkgo 30, Ramulus Uncariae Cum Uncis 25,
Poria 30, Radix Notoginseng 10, Radix Rehmanniae 30, Radix Glycyrrhizae 15, Rhizoma Chuanxiong 10,
Cordyceps 12.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021325480A CN1194730C (en) | 2002-07-08 | 2002-07-08 | Cardiac and cerebral blood vessel nourishing tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021325480A CN1194730C (en) | 2002-07-08 | 2002-07-08 | Cardiac and cerebral blood vessel nourishing tea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1387903A CN1387903A (en) | 2003-01-01 |
| CN1194730C true CN1194730C (en) | 2005-03-30 |
Family
ID=4746828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021325480A Expired - Fee Related CN1194730C (en) | 2002-07-08 | 2002-07-08 | Cardiac and cerebral blood vessel nourishing tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1194730C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1329049C (en) * | 2005-10-12 | 2007-08-01 | 牛西午 | Blood sugar- and blood pressure-lowering medicine |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101507502B (en) * | 2009-03-30 | 2012-06-06 | 安徽省农业科学院蚕桑研究所 | Bag tea containing Chinese caterpillar fungus and mulberry-leaf and preparation method thereof |
| CN104642659A (en) * | 2015-02-01 | 2015-05-27 | 顾明健 | Folium mori tea for reducing blood pressure |
| CN106344879A (en) * | 2016-10-26 | 2017-01-25 | 南宁多灵生物科技有限公司 | Traditional Chinese medicine for treating cerebral thrombosis |
| CN107456542A (en) * | 2017-09-12 | 2017-12-12 | 沈金山 | A kind of preparation method for treating hypertension ginkgo medicine |
-
2002
- 2002-07-08 CN CNB021325480A patent/CN1194730C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1329049C (en) * | 2005-10-12 | 2007-08-01 | 牛西午 | Blood sugar- and blood pressure-lowering medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1387903A (en) | 2003-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101129817B (en) | Chinese medicine formulation for treating hypertension and method of producing the same | |
| CN1319414A (en) | Medicine for treating hecrosis of femoral head | |
| CN1304744A (en) | Chinese medicine for curing hepatitis B and cirrhosis ascites | |
| CN1931329A (en) | Stomatocase treating medicine | |
| CN1194730C (en) | Cardiac and cerebral blood vessel nourishing tea | |
| CN101406594B (en) | Chinese medicine for treating tumor of lung | |
| CN1050046C (en) | Preparation method for medicine to cure flaccid paralysis | |
| CN1084197C (en) | Medicine for treating rheumatism, rheumatoid disease, hyperosteogeny and arthritis, and its preparing process | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN102038751A (en) | Traditional Chinese medicine formulation for treating infantile diarrhea | |
| CN1285378C (en) | Nourishing wine for regulating human body balance function | |
| CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN1057230C (en) | Traditional Chinese medicine capsule for treating thrombophlebitis | |
| CN104398975A (en) | Traditional Chinese medicinal preparation for treating fibroadenoma of breast and preparation method thereof | |
| CN1408384A (en) | Pure traditional Chinese medicine preparation for curing lung cancer | |
| CN1264592A (en) | Medicine for treating ichthyosis and preparing process thereof | |
| CN1058622C (en) | Rehabilitation powder for hepatitis B | |
| CN101732514B (en) | Medicament for treating rheumatism, rheumatoid arthritis, cervical osteoarthritis and lumbar osteoarthritis | |
| CN110123896B (en) | Pharmaceutical composition for adjuvant treatment of tumor and preparation method thereof | |
| CN102145119B (en) | Traditional Chinese medicinal composition for treating pulmonary heart diseases | |
| CN101884762B (en) | Traditional Chinese medicine for treating emphysema | |
| CN1049599C (en) | Medicine for treatment of thromboangiitis obliterans | |
| CN105770552A (en) | Chinese herba preparation containing folium artemisiae argyi and used for treating prostatitis and preparing method thereof | |
| CN1068217C (en) | Traditional Chinese medicine for treating skin disease and veneral disease | |
| CN105456447A (en) | Folium artemisiae argyi-containing traditional Chinese medicine composition with function of promoting blood circulation to remove stasis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |